MOLECULAR NETWORKS GMBH COMPUTERCHEMIE

Their core work

Molecular Networks is a German SME specializing in computational chemistry and cheminformatics software. They build predictive models and data integration platforms that help pharmaceutical and chemical companies assess the safety and toxicity of compounds without relying on animal testing. Their core work sits at the intersection of chemistry databases, machine learning, and regulatory toxicology — translating raw chemical and pre-clinical data into actionable risk predictions.

What they specialise in

How they've shifted over time

Their earliest H2020 involvement (BIGCHEM, 2016) focused broadly on big data methods in chemistry — a foundational capability-building phase. From 2017 onward, they sharpened their focus dramatically toward drug safety and toxicology data platforms (eTRANSAFE), and by 2021, moved further into AI-driven, animal-free toxicity prediction (ONTOX). The trajectory is clear: from general cheminformatics toward increasingly specialized, regulation-driven computational toxicology.

They are moving decisively toward AI and ontology-based methods for replacing animal testing in chemical safety assessment — a field with strong regulatory tailwinds from EU initiatives like the Green Deal and REACH reform.

How they like to work

Molecular Networks operates exclusively as a participant or third-party contributor — they have never coordinated an H2020 project. With 62 unique partners across 16 countries in just 3 projects, they work in large, multi-national consortia typical of IMI and major RIA actions. This suggests they bring a specific technical capability (computational tools, data platforms) to large collaborative efforts rather than driving the research agenda themselves.

Despite only 3 projects, they have built an unusually broad network of 62 partners across 16 countries — a consequence of participating in large-scale consortia like eTRANSAFE and ONTOX. Their network spans Western and Northern Europe with strong pharma-industry and academic connections.

What sets them apart

Their specific niche — computational chemistry software applied to regulatory toxicology — is rare among SMEs. While many academic groups do computational toxicology research, Molecular Networks brings production-grade cheminformatics tools and commercial data integration platforms to consortia. For anyone building a project around chemical safety, predictive toxicology, or animal-free testing methods, they fill the gap between academic algorithms and usable software infrastructure.

Highlights from their portfolio

• ONTOX
  Their largest funded project (EUR 921K), running until 2026, combining AI and ontology for animal-free toxicity testing — directly aligned with EU regulatory trends.
• eTRANSAFE
  Major IMI-style drug safety project (EUR 954K) focused on integrating pre-clinical and clinical safety data across the pharmaceutical industry.